Sitravatinib (MGCD516)

Sitravatinib (MGCD516, MG-516) is a novel small molecule inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Kit, PDGFRβ, PDGFRα, c-Met, and Axl.

Price Not Available 10mM/1mL Sitravatinib (MGCD516) Supplier Page

Trivial name	MG-516
Catalog Number	S8573
Molecular Formula	C33H29F2N5O4S
CAS#	1123837-84-2
Inchi	InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-1 5,18H2,1H3,(H,39,41)(H,40,42)
Inchi Key	WLAVZAAODLTUSW-UHFFFAOYSA-N
SMILES	COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
Size	10mM/1mL
Supplier Page	http://www.selleckchem.com/products/sitravatinib-mgcd516.html
Additional Information	https://file.selleck.cn/downloads/struct/sitravatinib-mgcd516-chemical-structure-S8573.gif